← Leaderboards
Kara N Maxwell
University Of Pennsylvania
$923,845
Attributed
$923,845
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $228K · FY2018–25$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$923,845 · 1
VA$0 · 3
By mechanism
K08$923,845 · 1
I01$0 · 3
Top collaborators
- Saiju Pyarajan3 shared
- Isla Pearl Garraway2 shared
- Michael J Kelley2 shared
- Antonio Tito Fojo1 shared
- Martin Schoen1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Emile R. Mohler$6,792,861
- Mary D Naylor$10,965,438
- Kathryn Helene Bowles$16,286,736
- Roger A Greenberg$15,375,785
- Yehoda Marteki Martei$547,916
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsTumorCancer PatientSelection For TreatmentsPatient SelectionGenomicsClinical TrialsResourcesTreatment ResponseMutationLoss Of HeterozygosityTissuesExome SequencingMolecularHomologous RecombinationDna RepairPhenotypeSamplingBaseMalignant Breast NeoplasmCategoriesNeoplasm MetastasisCancer RiskCancer Therapy
Grant awards (10)
Creating precision in metastatic hormone sensitive prostate cancer: Using tumor genetics and patient characteristics to predict outcomes and improve treatment selection$0
I01 · FY2025 · VA
Multi-level factors impacting clinical outcomes in Veterans with low-/intermediate-risk prostate cancer$0
I01 · FY2025 · VA
Mutational processes underlying tumor development in United States Veterans$0
I01 · FY2024 · VA · contact PI
Mutational processes underlying tumor development in United States Veterans$0
I01 · FY2024 · VA · contact PI
A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes$173,969
K08 · FY2022 · CA · contact PI
A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes$173,969
K08 · FY2021 · CA · contact PI
A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes$173,969
K08 · FY2020 · CA · contact PI
A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes$54,000
K08 · FY2020 · CA · contact PI
A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes$173,969
K08 · FY2019 · CA · contact PI
A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes$173,969
K08 · FY2018 · CA · contact PI